From the potent and selective μ opioid receptor agonist H-Dmt-D-Arg-Phe-Lys-NH2 to the potent δ antagonist H-Dmt-Tic-Phe-Lys(Z)-OH

被引:5
作者
Balboni, G [1 ]
Cocco, MT
Salvadori, S
Romagnoli, R
Sasaki, Y
Okada, Y
Bryant, SD
Jinsmaa, Y
Lazarus, LH
机构
[1] Univ Cagliari, Dept Toxicol, I-09124 Cagliari, Italy
[2] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[3] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy
[4] Tohoku Pharmaceut Univ, Aoba Ku, Sendai, Miyagi 9818558, Japan
[5] Kobe Gakuin Univ, Fac Pharmaceut Sci, Dept Med Chem, Kobe, Hyogo 6512180, Japan
[6] Kobe Gakuin Univ, High Technol Res Ctr, Kobe, Hyogo 6512180, Japan
[7] NIEHS, Lab Pharmacol & Chem, Med Chem Grp, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1021/jm0504959
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
H-Dmt-D-Arg-Phe-Lys-NH2 ([Dmt(1)]DALDA) binds with high affinity and selectivity to the mu opioid receptor and is a potent and long-acting analgesic. Substitution of D-Arg in position 2 with Tic and masking of the lysine amine side chain by Z protection and of the C-terminal carboxylic function instead of the amide function transform a potent and selective mu agonist into a potent and selective delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH. Such a delta antagonist could be used as a pharmacological tool.
引用
收藏
页码:5608 / 5611
页数:4
相关论文
共 23 条
[1]  
ABDELHAMID EE, 1991, J PHARMACOL EXP THER, V258, P299
[2]   Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on δ-opioid receptor selectivity and antagonism [J].
Balboni, G ;
Salvadori, S ;
Guerrini, R ;
Negri, L ;
Giannini, E ;
Bryant, SD ;
Jinsmaa, Y ;
Lazarus, LH .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (16) :4066-4071
[3]   Synthesis and opioid activity of N,N-dimethyl-Dmt-Tic-NH-CH(R)-R′ analogues:: Acquisition of potent δ antagonism [J].
Balboni, G ;
Salvadori, S ;
Guerrini, R ;
Negri, L ;
Giannini, E ;
Bryant, SD ;
Jinsmaa, Y ;
Lazarus, LH .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (24) :5435-5441
[4]   Potent δ-opioid receptor agonists containing the Dmt-Tic pharmacophore [J].
Balboni, G ;
Salvadori, S ;
Guerrini, R ;
Negri, L ;
Giannini, E ;
Jinsmaa, Y ;
Bryant, SD ;
Lazarus, LH .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (25) :5556-5563
[5]   Dmt and opioid peptides: A potent alliance [J].
Bryant, SD ;
Jinsmaa, Y ;
Salvadori, S ;
Okada, Y ;
Lazarus, LH .
BIOPOLYMERS, 2003, 71 (02) :86-102
[6]   Inhibition of Akt/protein kinase B signaling by naltrindole in small cell lung cancer cells [J].
Chen, YL ;
Law, PY ;
Loh, HH .
CANCER RESEARCH, 2004, 64 (23) :8723-8730
[7]  
FANG FG, 1986, J PHARMACOL EXP THER, V238, P1039
[8]  
Gavériaux-Ruff C, 2001, J PHARMACOL EXP THER, V298, P1193
[9]   Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene [J].
Matthes, HWD ;
Maldonado, R ;
Simonin, F ;
Valverde, O ;
Slowe, S ;
Kitchen, I ;
Befort, K ;
Dierich, A ;
LeMeur, M ;
Dolle, P ;
Tzavara, E ;
Hanoune, J ;
Roques, BP ;
Kieffer, BL .
NATURE, 1996, 383 (6603) :819-823
[10]  
Nitsche JF, 2002, J NEUROSCI, V22, P10906